止血
纤维蛋白
凝结
微球
明胶
血小板
生物医学工程
纤维蛋白原
化学
凝块形成
纳米技术
材料科学
血小板粘附
微粒
生物物理学
全血
基质(化学分析)
凝血酶
止血剂
血小板活化
止血剂
血小板聚集
自愈水凝胶
生物相容性材料
作者
Yuanyuan Ding,Ting Wang,Jing Li,Yue Li,Mengting Chen,Ju‐E Cun,Bin He
标识
DOI:10.1002/adhm.202505052
摘要
Rapid capture of fibrin and platelets is critical in high-pressure hemorrhage. However, many conventional hemostatic agents fail to sequester fibrin and assemble a stable clot, which limits their effectiveness in emergency care. In this study, hydroxyapatite (HAp)-doped gelatin microspheres (GHMPs-10) are developed to enhance hemostasis in high-pressure hemorrhage by accelerating the coagulation process. Initially, the surface-exposed HAp domains of GHMPs-10 facilitates the rapid recruitment of fibrinogen and its subsequent assembly into a robust network, enhancing the entrapment of platelets and erythrocytes to stabilize the thrombus. In addition, hydrophilic groups in the gelatin matrix enable rapid fluid uptake and microsphere expansion (≈718%). This concentrates local coagulation factors and platelets and accelerates fibrin network formation, while the expanded microspheres mechanically occlude the injury site. Functionally, GHMPs-10 withstood ≈191.5 mmHg in burst-pressure testing and, across multiple animal models, achieved shorter hemostasis times with lower blood loss than commercial powders. By rapidly initiating coagulation and concentrating blood components to form a mechanically robust hydrogel clot, these fibrinogen-capturing microspheres emerge as a highly promising candidate for rapid hemostasis, with potential for clinical translation.
科研通智能强力驱动
Strongly Powered by AbleSci AI